IRCT20200105046010N43尚未招募未知
In- Vivo Bioequivalence Study of Dimethyl fumarate 240 mg Enteric-coated test (DIPHOSEL® 240 mg EC. Caps. ?Abidi, Iran) with brand drug (TECFIDERA® 240 mg, Biogen, Germany) in Iranian healthy volunteers.
ABIDI Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health
- •Body mass index between18-28
- •Informed consent
- •Being at the age of 18-60 years old
排除标准
- •History of cardiovascular disease
- •History of liver or kidney disease
- •Alcohol & Drug addiction
- •History of hypersensitivity
研究者
相似试验
尚未招募
不适用
Study of absorption and elimination rate of Dimethyl Fumarate 240-mg capsule in comparison with Dimethyl Fumarate brand Capsule (Tecfidera®).Bioequivalence study.IRCT20200407046981N27Avicenna Pharmaceutical Company24
尚未招募
不适用
Bioequivalence study of dimethyl fumarate 240 mg capsuleThis study is performed on healthy volunteers..IRCT20200623047902N26Alborz Zagros company24
尚未招募
2 期
The Efficacy of dimethyl fumarate in the treatment of patients with COVID-19IRCT20201024049134N4Babol University of Medical Sciences30
进行中（未招募）
1 期
Dimethylfumarate for the treatment of Palmoplantar PustulosisPalmoplantar PustulosisMedDRA version: 20.0Level: LLTClassification code 10050185Term: Palmoplantar pustulosisSystem Organ Class: 100000004858EUCTR2017-003386-10-ATMedical University of Vienna25
招募中
Unknown
Bioequivalence study of Famotidine SuspensioIn the present study, the products will be administered to healthy volunteers.IRCT20210519051345N44Tabriz University of Medical Sciences24